Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behaviour

Daniel Hernandez, Laia Miquel-Serra, Maria Jose Docampo, Anna Marco-Ramell, Anna Bassols

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Abstract

Versican is a hyaluronan-binding, large extracellular matrix chondroitin sulfate proteoglycan whose expression is increased in malignant melanoma. Binding to hyaluronan allows versican to indirectly interact with the hyaluronan cell surface receptor CD44. The aim of this work was to study the effect of silencing the large versican isoforms (V0 and V1) and CD44 in the SK-mel-131 human melanoma cell line. Versican V0/V1 or CD44 silencing caused a decrease in cell proliferation and migration, both in wound healing assays and in Transwell chambers. Versican V0/V1 silencing also caused an increased adhesion to type I collagen, laminin and fibronectin. These results support the proposed role of versican as a proliferative, anti-adhesive and pro-migratory molecule. On the other hand, CD44 silencing caused a decrease in cell adhesion to vitronectin, fibronectin and hyaluronan. CD44 silencing inhibited the binding of a FITC-hyaluronan complex to the cell surface and its internalization into the cytoplasm. Our results indicate that both versican and CD44 play an important role regulating the behavior of malignant melanoma cells.
Original languageEnglish
Pages (from-to)269-275
JournalInternational Journal of Molecular Medicine
Volume27
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Dive into the research topics of 'Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behaviour'. Together they form a unique fingerprint.

Cite this